CELLCEPT

Capsule, hard, 250mg
RxActive license

Active substance (INN)

mycophenolic acid

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength250mg
PackagingUkupno 100 kapsula tvrdih u blisteru (10x10) u kartonskoj kutiji
ManufacturerRoche Pharma AG, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L04AA06)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateFebruary 21, 2025

Analogs in Montenegro

3

Other medicines with the same active substance

CELLCEPTRx
Film-coated tablet, 500mgF. Hoffmann-La Roche AG
MYFORTICRx
Gastro-resistant tablet, 180mgNovartis Pharma Produktions GmbH
MYFORTICRx
Gastro-resistant tablet, 360mgNovartis Pharma Produktions GmbH
Source: CInMED register